EFFICACY OF AMPICILLIN VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE IN A MOUSE MODEL OF LETHAL ENTEROCOCCAL PERITONITIS

被引:26
|
作者
CHENOWETH, CE [1 ]
ROBINSON, KA [1 ]
SCHABERG, DR [1 ]
机构
[1] UNIV MICHIGAN,DEPT INTERNAL MED,DIV INFECT DIS,ANN ARBOR,MI 48109
关键词
D O I
10.1128/AAC.34.9.1800
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Lethal enterococcal peritonitis in mice was used to compare trimethoprim-sulfamethoxazole (TMP-SMX) therapy with ampicillin therapy. Peritoneal fluid showed a 103-CFU decrease in enterococci with ampicillin compared with TMP-SMX. Mortality of the untreated mice was 100%, compared with 40% for ampicillin and 95% for TMP-SMX, despite adequately measured levels in serum and peritoneal fluid.
引用
收藏
页码:1800 / 1802
页数:3
相关论文
共 50 条
  • [21] Clindamycin versus Trimethoprim-Sulfamethoxazole for Uncomplicated Skin Infections
    Miller, Loren G.
    Daum, Robert S.
    Creech, C. Buddy
    Young, David
    Downing, Michele D.
    Eells, Samantha J.
    Pettibone, Stephanie
    Hoagland, Rebecca J.
    Chambers, Henry F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (12): : 1093 - 1103
  • [22] Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess
    Talan, David A.
    Mower, William R.
    Krishnadasan, Anusha
    Abrahamian, Fredrick M.
    Lovecchio, Frank
    Karras, David J.
    Steele, Mark T.
    Rothman, Richard E.
    Hoagland, Rebecca
    Moran, Gregory J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (09): : 823 - 832
  • [23] TRIMETHOPRIM-SULFAMETHOXAZOLE FOR THE PREVENTION OF SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOSIS - A RANDOMIZED TRIAL
    SINGH, N
    GAYOWSKI, T
    YU, VL
    WAGENER, MM
    ANNALS OF INTERNAL MEDICINE, 1995, 122 (08) : 595 - 598
  • [24] PHARMACOKINETICS AND EFFICACY OF TRIMETHOPRIM-SULFAMETHOXAZOLE IN TREATMENT OF GASTROENTERITIS IN CHILDREN
    MARKS, MI
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1975, 112 : S33 - S34
  • [25] Use of colistin with rifampicin, trimethoprim-sulfamethoxazole and teicoplanin in Acinetobacter mouse infection model
    Yesil, Cihan
    Yalcin, Ata N.
    Ogunc, Dilara
    Ongut, Gozde
    Ozhak, Betul
    Colak, Dilek
    Er, Halil
    Saritas, Zubeyde E.
    FUTURE MICROBIOLOGY, 2022, 17 (09) : 665 - 671
  • [26] CLINICAL-TRIAL OF AMPICILLIN V TRIMETHOPRIM-SULFAMETHOXAZOLE IN THE TREATMENT OF SHIGELLA DYSENTERY
    YUNUS, M
    RAHMAN, ASMM
    FAROOQUE, ASG
    GLASS, RI
    JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1982, 85 (05): : 195 - 199
  • [27] TRIMETHOPRIM-SULFAMETHOXAZOLE FOR THE PREVENTION OF SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOSIS - A PROSPECTIVE RANDOMIZED TRIAL
    SINGH, N
    GAYOWSKI, T
    WAGENER, MM
    YU, VL
    HEPATOLOGY, 1994, 20 (04) : A115 - A115
  • [28] The efficacy of trimethoprim-sulfamethoxazole treatment in children with acute bloody diarrhea
    Nafianti, Selvi
    Ramayani, Oke R.
    Daulay, Dedy G.
    Supriatmo
    Hasibuan, Berlian
    Sinuhaji, Atan B.
    PAEDIATRICA INDONESIANA, 2007, 47 (01) : 17 - 20
  • [29] Efficacy of prophylactic use of trimethoprim-sulfamethoxazole in autoimmune neutropenia in infancy
    Kobayashi, M
    Sato, T
    Kawaguchi, H
    Nakamura, K
    Kihara, H
    Hiraoka, A
    Tanihiro, M
    Taniguchi, K
    Takata, N
    Ueda, K
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (07) : 553 - 557
  • [30] Comparison of trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscesses
    Gottlieb, Michael
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2017, 19 (04) : 308 - 311